Under the terms of the multi-year contract, AFYREN will provide its biobased acids for applications such as preservatives and flavors for nutritional supplements.
“The multi-billion-dollar nutraceuticals market is expected to grow in the high-single digits over the next years, driven by consumer appetite for products that can improve their overall health and well-being, with a focus on natural and sustainable ingredients,” AFYREN said in a press statement.
AFYREN’s first plant, AFYREN NEOXY, a joint venture with Bpifrance’s SPI fund, is located in the Grand-Est region of France, in Saint Avold, serving mainly the European market.
AFYREN is also pursuing a project in Thailand with a world leader in the sugar industry, and is developing its presence in the Americas, following up on distribution agreements it has already signed.